Frontiers in Cellular and Infection Microbiology (Sep 2023)
Contribution of viral and bacterial infections to senescence and immunosenescence
- Antonia Reyes,
- Antonia Reyes,
- Gerardo Ortiz,
- Gerardo Ortiz,
- Luisa F. Duarte,
- Luisa F. Duarte,
- Luisa F. Duarte,
- Christian Fernández,
- Christian Fernández,
- Rosario Hernández-Armengol,
- Rosario Hernández-Armengol,
- Pablo A. Palacios,
- Pablo A. Palacios,
- Yolanda Prado,
- Yolanda Prado,
- Catalina A. Andrade,
- Catalina A. Andrade,
- Linmar Rodriguez-Guilarte,
- Linmar Rodriguez-Guilarte,
- Alexis M. Kalergis,
- Alexis M. Kalergis,
- Alexis M. Kalergis,
- Felipe Simon,
- Felipe Simon,
- Leandro J. Carreño,
- Leandro J. Carreño,
- Claudia A. Riedel,
- Claudia A. Riedel,
- Mónica Cáceres,
- Mónica Cáceres,
- Pablo A. González,
- Pablo A. González
Affiliations
- Antonia Reyes
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Antonia Reyes
- Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
- Gerardo Ortiz
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Gerardo Ortiz
- Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
- Luisa F. Duarte
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Luisa F. Duarte
- Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
- Luisa F. Duarte
- Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile
- Christian Fernández
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Christian Fernández
- Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile
- Rosario Hernández-Armengol
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Rosario Hernández-Armengol
- Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile
- Pablo A. Palacios
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Pablo A. Palacios
- Programa de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile
- Yolanda Prado
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Yolanda Prado
- Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile
- Catalina A. Andrade
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Catalina A. Andrade
- Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
- Linmar Rodriguez-Guilarte
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Linmar Rodriguez-Guilarte
- Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
- Alexis M. Kalergis
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Alexis M. Kalergis
- Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
- Alexis M. Kalergis
- Departamento de Endocrinología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
- Felipe Simon
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Felipe Simon
- Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile
- Leandro J. Carreño
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Leandro J. Carreño
- Programa de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile
- Claudia A. Riedel
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Claudia A. Riedel
- Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile
- Mónica Cáceres
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Mónica Cáceres
- Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile
- Pablo A. González
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Pablo A. González
- Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
- DOI
- https://doi.org/10.3389/fcimb.2023.1229098
- Journal volume & issue
-
Vol. 13
Abstract
Cellular senescence is a key biological process characterized by irreversible cell cycle arrest. The accumulation of senescent cells creates a pro-inflammatory environment that can negatively affect tissue functions and may promote the development of aging-related diseases. Typical biomarkers related to senescence include senescence-associated β-galactosidase activity, histone H2A.X phosphorylation at serine139 (γH2A.X), and senescence-associated heterochromatin foci (SAHF) with heterochromatin protein 1γ (HP-1γ protein) Moreover, immune cells undergoing senescence, which is known as immunosenescence, can affect innate and adaptative immune functions and may elicit detrimental effects over the host’s susceptibility to infectious diseases. Although associations between senescence and pathogens have been reported, clear links between both, and the related molecular mechanisms involved remain to be determined. Furthermore, it remains to be determined whether infections effectively induce senescence, the impact of senescence and immunosenescence over infections, or if both events coincidently share common molecular markers, such as γH2A.X and p53. Here, we review and discuss the most recent reports that describe cellular hallmarks and biomarkers related to senescence in immune and non-immune cells in the context of infections, seeking to better understand their relationships. Related literature was searched in Pubmed and Google Scholar databases with search terms related to the sections and subsections of this review.
Keywords